A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference37 articles.
1. A bad tumor biomarker is as bad as a bad drug: the gap between genomics data and phenotype to predict response;Viale;Breast,2015
2. Tailoring therapies–improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015;Coates;Ann Oncol,2015
3. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017;Curigliano;Ann Oncol,2017
4. Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study;McCullough;Breast Cancer Res Treat,2014
5. Discordance in pathology report after central pathology review: implications for breast cancer adjuvant treatment;Orlando;Breast,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A theoretical approach to study the frequency dependent dielectric behavior of breast cancer cells using AlN buffer-based AlGaN/GaN HEMT;Physica Scripta;2024-05-14
2. Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of ESR1, PGR, ERBB2, MKI67, and a Novel Proliferation Signature;Diagnostics;2024-01-23
3. Dual-miRNA-Propelled Three-Dimensional DNA Walker for Highly Specific and Rapid Discrimination of Breast Cancer Cell Subtypes in Clinical Tissue Samples;CCS Chemistry;2022-08-02
4. State-of-the-art cancer biomarker detection by portable (Bio) sensing technology: A critical review;Microchemical Journal;2022-06
5. Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond;Seminars in Cancer Biology;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3